Author Title Type [ Year(Asc)]
Filters: First Letter Of Title is R  [Clear All Filters]
Morishima Y, Morishima S, Stevenson P, Kodera Y, Horowitz M, McKallor C, Malkki M, Spellman SR, Gooley T, Petersdorf EW. Race and Survival in Unrelated Hematopoietic-cell Transplantation. Transplant Cell Ther. 2022.
Bogart JA, Waqar SN, Mix MD. Radiation and Systemic Therapy for Limited-Stage Small-Cell Lung Cancer. J Clin Oncol. 2022:JCO2101639.
Wang B, Hu J, Zhang J, Zhao L. Radiation therapy regulates TCF-1 to maintain CD8+T cell stemness and promotes anti-tumor immunotherapy. Int Immunopharmacol. 2022;107:108646.
Kiumarsi A, Mousavi SAli, Kasaeian A, Rostami T, Rad S, Ghavamzadeh A, Mousavi SAsadollah. Radiation-free Reduced-intensity Hematopoietic Stem Cell Transplantation with In-Vivo T-cell Depletion from Matched Related and Unrelated Donors for Fanconi Anemia: Prognostic Factor Analysis. Exp Hematol. 2022.
Suda S, Nito C, Ihara M, Iguchi Y, Urabe T, Matsumaru Y, Sakai N, Kimura K. Randomised placebo-controlled multicentre trial to evaluate the efficacy and safety of JTR-161, allogeneic human dental pulp stem cells, in patients with Acute Ischaemic stRoke (J-REPAIR). BMJ Open. 2022;12(5):e054269.
Jiang Y, Li X, Guo T, Lu W-J, Ma S, Chang Y, Song Y, Zhang S, Bai R, Wang H, et al. Ranolazine rescues the heart failure phenotype of PLN-deficient human pluripotent stem cell-derived cardiomyocytes. Stem Cell Reports. 2022.
Ren X, Lei W, Huang S, Shi D, Li X. Rapamycin Treatment Is Beneficial for the Generation of Rabbit-Induced Pluripotent Stem-Like Cells. Cell Reprogram. 2022.
Buchheit KM, Sohail A, Hacker J, Maurer R, Gakpo D, Bensko JC, Taliaferro F, Ordovas-Montanes J, Laidlaw TM. Rapid and sustained effect of dupilumab on clinical and mechanistic outcomes in aspirin-exacerbated respiratory disease. J Allergy Clin Immunol. 2022.
Clevenger AJ, Crawford LZ, Noltensmeyer D, Babaei H, Mabbott SB, Avazmohammadi R, Raghavan S. Rapid Prototypable Biomimetic Peristalsis Bioreactor Capable of Concurrent Shear and Multi-axial Strain. Cells Tissues Organs. 2022.
Cobo MFernanda L, Welters C, Rosenberger L, Leisegang M, Dietze K, Pircher C, Penter L, Gary R, Bullinger L, Takvorian A, et al. Rapid single-cell identification of Epstein-Barr virus-specific T-cell receptors for cellular therapy. Cytotherapy. 2022.
Mahajan RG, Joyce HMosainder, Green N, Hijiya N, Jain N. Rare Presentation of Atypical Hemolytic Uremic Syndrome in a Child With Acute Lymphocytic Leukemia and Pancreatitis. J Pediatr Hematol Oncol. 2022.
Huang H, Christidi E, Shafaattalab S, Davis MK, Tibbits GF, Brunham LR. RARG S427L attenuates the DNA repair response to doxorubicin in induced pluripotent stem cell-derived cardiomyocytes. Stem Cell Reports. 2022.
Antonenko YN, Jędrzejczyk M, Rokitskaya TI, Khailova LS, Kotova EA, Huczyński A. Rate of translocation across lipid bilayer of triphenylphosphonium-linked salinomycin derivatives contributes significantly to their K/H exchange activity on membranes. Bioelectrochemistry. 2022;145:108089.
Ma Y, Guo Z, Fan C, Chen J, Xu S, Liu Z. Rationally Screened and Designed ABCG2-Binding Aptamers for Targeting Cancer Stem Cells and Reversing Multidrug Resistance. Anal Chem. 2022.
Mu W, Murcia NS, Smith KN, Menon DU, Yee D, Magnuson T. RBBP4 dysfunction reshapes the genomic landscape of H3K27 methylation and acetylation and disrupts gene expression. G3 (Bethesda). 2022.
Ma S-P, Gao X-X, Zhou G-Q, Zhang H-K, Yang J-M, Wang W-J, Song X-M, Chen H-Y, Lu D-R. Reactivation of γ-globin expression using a minicircle DNA system to treat β-thalassemia. Gene. 2022:146289.
Leroy A, Devaux M-F, Fanuel M, Chauvet H, Durand S, Alvarado C, Habrant A, Sandt C, Rogniaux H, Paës G, et al. Real-time imaging of enzymatic degradation of pretreated maize internodes reveals different cell types have different profiles. Bioresour Technol. 2022:127140.
Serrano P, Yuen HWah, Akdemir J, Hartmann M, Reinholz T, Peltier S, Ligensa T, Seiller C, Le Bourhis AParaiso. Real-world data in drug development strategies for orphan drugs: tafasitamab in B cell lymphoma, a case study for approval based on a single-arm combination trial. Drug Discov Today. 2022.
Puckrin R, Stewart DA, Shafey M. Real-world eligibility for second-line CAR-T cell therapy in large B-cell lymphoma: a population-based analysis. Transplant Cell Ther. 2022.
Jalbert JJ, Wu N, Chen C-I, Ambati S, Ge W, Arnason JE. Real-World Treatment Patterns After CD19-Directed CAR T Cell Therapy Among Patients with Diffuse Large B Cell Lymphoma. Adv Ther. 2022.
Narkhede M, Goyal G, Shea L, Mehta A, Giri S. Real-World Treatment Patterns and Outcomes of Mantle Cell Lymphoma. Blood Adv. 2022.
Hajra A, Safiriyu I, Balasubramanian P, Gupta R, Chowdhury S, Prasad AJ, Kumar A, Kumar D, Khan B, Bilberry RSF, et al. Recent Advances and Future Prospects of Treatment of Pulmonary Hypertension. Curr Probl Cardiol. 2022:101236.
Bradu P, Biswas A, Nair C, Sreevalsakumar S, Patil M, Kannampuzha S, Mukherjee AGoutam, Wanjari URamesh, Renu K, Vellingiri B, et al. Recent advances in green technology and Industrial Revolution 4.0 for a sustainable future. Environ Sci Pollut Res Int. 2022.
Aldoghachi AFaris, Aldoghachi AFaris, Bryne K, Ling K-H, Cheah PSee. Recent advances in the therapeutic strategies of glioblastoma multiforme. Neuroscience. 2022.
Horgan C, Serroukh Y, Gjærde LKlingen, Gagelmann N. Recognising inequalities in haematopoietic stem-cell transplantation and cellular therapy training. Lancet Haematol. 2022.